Stokes Family Office’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.28M | Buy |
4,208
+96
| +2% | +$74.8K | 0.34% | 67 |
|
|
2025
Q1 | $3.4M | Buy |
4,112
+4
| +0.1% | +$3.3K | 0.38% | 63 |
|
|
2024
Q4 | $3.17M | Sell |
4,108
-148
| -3% | -$114K | 0.34% | 68 |
|
|
2024
Q3 | $3.77M | Sell |
4,256
-50
| -1% | -$44.3K | 0.41% | 58 |
|
|
2024
Q2 | $3.9M | Buy |
4,306
+384
| +10% | +$348K | 0.46% | 54 |
|
|
2024
Q1 | $3.05M | Sell |
3,922
-231
| -6% | -$180K | 0.38% | 64 |
|
|
2023
Q4 | $2.42M | Sell |
4,153
-722
| -15% | -$421K | 0.33% | 70 |
|
|
2023
Q3 | $2.62M | Buy |
4,875
+245
| +5% | +$132K | 0.31% | 73 |
|
|
2023
Q2 | $2.17M | Sell |
4,630
-26
| -0.6% | -$12.2K | 0.25% | 78 |
|
|
2023
Q1 | $1.6M | Sell |
4,656
-153
| -3% | -$52.5K | 0.2% | 88 |
|
|
2022
Q4 | $1.76M | Buy |
4,809
+386
| +9% | +$141K | 0.23% | 77 |
|
|
2022
Q3 | $1.43M | Buy |
4,423
+121
| +3% | +$39.1K | 0.2% | 86 |
|
|
2022
Q2 | $1.4M | Buy |
4,302
+98
| +2% | +$31.8K | 0.19% | 88 |
|
|
2022
Q1 | $1.2M | Sell |
4,204
-258
| -6% | -$73.9K | 0.16% | 88 |
|
|
2021
Q4 | $1.23M | Buy |
4,462
+64
| +1% | +$17.7K | 0.15% | 87 |
|
|
2021
Q3 | $1.02M | Buy |
4,398
+41
| +0.9% | +$9.47K | 0.14% | 94 |
|
|
2021
Q2 | $1M | Buy |
4,357
+128
| +3% | +$29.4K | 0.14% | 94 |
|
|
2021
Q1 | $789K | Buy |
4,229
+104
| +3% | +$19.4K | 0.12% | 102 |
|
|
2020
Q4 | $697K | Buy |
4,125
+488
| +13% | +$82.5K | 0.14% | 100 |
|
|
2020
Q3 | $538K | Buy |
3,637
+175
| +5% | +$25.9K | 0.12% | 102 |
|
|
2020
Q2 | $568K | Sell |
3,462
-91
| -3% | -$14.9K | 0.14% | 99 |
|
|
2020
Q1 | $493K | Buy |
3,553
+24
| +0.7% | +$3.33K | 0.13% | 97 |
|
|
2019
Q4 | $464K | Buy |
+3,529
| New | +$464K | 0.1% | 100 |
|